Canary Oncoceutics posts about
CAR T-cell therapy

Stay informed, stay productive with all the latest from Canary Oncoceutics.

All Canary Cancer ctDNA CGP DNA Oncoceutics Medical Cancer Treatment Gene Germline Somatic Testing Repair RNA Genomic testing Tumor Genetics Research MSI Journal Cancer Diagnostics Tissue Liquid Biopsies Cancer Research Tumor-informed assays Oncology TMB Mutation Cancer Screening Preventive Care Infection Bone Marrow Sequencing Genomics Sanger Biomarkers Liquid Biopsy TILS PGx NGS Reference Materials Drug resistance Cancer Care Lifestyle Factors Clinical Trials NGS Workflow Classification Cancer Management pharmacogenomics Cancer care Somatic variant Cancer Syndromes Genetic Mutations Cancer Monitoring MRD CUP Clinical Trial Designs T-cell Receptor TCR Prostate Health PSA Test Cancer pathology Gleason score Prostate PSA CAR T-cell therapy Scientific Blog CAR-NK Cell therapy CAR-NK Cell Therapy
CAR T-Cell vs CAR-NK Cell Therapy

CAR T-Cell vs CAR-NK Cell Therapy

By Harry Lander on September 11, 2025

Compare CAR T-cell and CAR-NK therapies—their benefits, risks, manufacturing challenges, and future potential in cancer treatment.
CanaryScientific BlogCAR-NK Cell TherapyCAR T-cell therapy
Challenges in CAR T-Cell Therapy

Challenges in CAR T-Cell Therapy

By Harry Lander on September 1, 2025

Explore the challenges of CAR T cell therapy from toxicities and tumor resistance to manufacturing hurdles and the strategies shaping its future success.
CanaryCancer CareCAR T-cell therapy
CAR T-Cell Therapy: Transforming the Future of Cancer Treatment

CAR T-Cell Therapy: Transforming the Future of Cancer Treatment

By Harry Lander on August 22, 2025

Explore how CAR T cell therapy is reshaping cancer treatment by empowering the immune system to target and destroy cancer cells.
CanaryCancer CareCAR T-cell therapy